Should adults 50 and older talk to their doctor about RSV vaccination?

Respiratory syncytial virus, or RSV, is not just a baby illness. In older adults and in people with certain health conditions, it can cause serious respiratory illness and hospitalization.

That is why CDC’s current adult guidance is worth a fresh look before next winter. For some adults 50 and older, the question is whether an RSV vaccine fits their age and risk profile now, before respiratory virus season ramps up.

What CDC says now

CDC currently recommends a single dose of RSV vaccine for all adults ages 75 and older and for adults ages 50 to 74 who are at increased risk of severe RSV illness. In its 2025 adult immunization addendum, CDC also said adults ages 50 to 59 who are at increased risk should receive a single dose.

CDC’s adult schedule is also clear that RSV vaccination is not an annual shot. People who have already received one RSV vaccine dose are not recommended to receive another dose at this time.

Who may benefit most

The biggest issue for readers in their 50s is risk. CDC says adults ages 50 to 74 who have certain medical conditions or other risk factors may benefit from vaccination, including some chronic heart, lung, kidney, liver, neurologic, blood, or immune conditions, severe obesity, nursing home residence, and other factors a clinician thinks increase risk.

For adults 75 and older, CDC recommends RSV vaccination based on age alone. In plain language, the recommendation is risk-based for some younger older adults and routine for the oldest adults.

Why timing matters

Eligible adults can get an RSV vaccine at any time, but CDC says the best time is late summer or early fall, before RSV usually starts spreading in the community. In most of the continental United States, that means about August through October.

Waiting until someone is already sick does not help with prevention. Planning ahead can also make it easier to coordinate RSV vaccination with flu or COVID-19 shots if needed.

What to ask at the pharmacy or doctor’s office

If you think you may qualify, a pharmacist or clinician can help confirm:

whether your age puts you in a recommended group,
whether your medical history makes you higher risk,
whether you have already had an RSV vaccine dose, and
whether the timing makes sense this season.

That last question matters because CDC’s current guidance is based on a single-dose approach for eligible adults, not routine yearly dosing.

The bottom line

CDC’s current RSV guidance is simple, but it is still risk-based for many adults in their 50s through early 70s. For adults 50 and older, especially those with higher-risk health conditions, the practical next step is to check your own status with a clinician or pharmacist before next winter arrives.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.